MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation - Concepedia

Concepedia

Publication | Closed Access

MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation

83

Citations

26

References

2011

Year

Li Wang, Kathy A. Mason, K. Kian Ang, Thomas A. Buchholz, David R. Valdecanas, Anjili Mathur, Carolyn Buser‐Doepner, Carlo Toniatti, Luka Milas

Investigational New Drugs

Tumor BiologyHuman LungMedicinePharmacologyBreast Cancer XenograftsAnti-cancer AgentCell BiologyCancer TreatmentOncologyRadiation OncologyLung CancerCancer ResearchParp-1/-2 Inhibitor

References

	Year	Citations

Page 1

Page 1